Table 2 In-Hospital Clinical Events.

From: Comparison of Systematic Ticagrelor-Based Dual Antiplatelet Therapy to Selective Triple Antithrombotic Therapy for Left Ventricle Dysfunction Following Anterior STEMI

 

CHUM (Selective TATT)

N = 69

CHUS (Ticagrelor-DAPT)

N = 108

Unadjusted p-value

MACCE

7 (10%)

21 (19%)

0.139

  Death

3 (4%)

7 (6%)

0.742

  Myocardial Infarction

1 (1%)

0 (0%)

0.390

  Unplanned Revascularization

2 (3%)

15 (14%)

0.018*

   TLR

0 (0%)

5 (5%)

0.158

   Non-TLR

2 (3%)

10 (9%)

0.131

  Stroke/TIA

1 (1%)

0 (0%)

0.390

Major Bleeding

4 (6%)

0 (0%)

0.022*

  In-Hospital Transfusion

4 (6%)

1 (1%)

0.074

LVT*

0 (0%)

0 (0%)

—

  1. MACCE: Major adverse cardiovascular and cerebrovascular event. TLR: Target lesion revascularization. LVT: Left ventricular thrombus.
  2. *LVT was an exclusion criterion for this analysis.
Back to article page